You have 9 free searches left this month | for more free features.

Hepatitis B and C

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acceptability ofPrEP Program Among MSM and Transgender and

Not yet recruiting
  • HIV Infections
  • STI
  • acceptability of a PrEP program among HIV-negative MSM and TG
  • (no location specified)
Jul 10, 2023

Viral Hepatitis B, C and HIV Among Drug Users in

Recruiting
  • Hepatitis C
  • +4 more
    • Limoges, Haute Vienne, France
      Chu Limoges
    May 3, 2022

    Viral Hepatitis Trial in Tháng 07 (Continuing medical education)

    Enrolling by invitation
    • Viral Hepatitis
    • Continuing medical education
    • Tháng 07, Ho Chi Minh City, Vietnam
      Lê Hồng Đức
    Jan 11, 2022

    Combined Point of Care Diagnostic of HIV, HBV and HCV Trial in Marseille (MagIA IBC test in capillary blood, MagIA IBC test in

    Recruiting
    • Combined Point of Care Diagnostic of HIV, HBV and HCV
    • MagIA IBC test in capillary blood
    • MagIA IBC test in other matrices
    • Marseille, France
      Hopital Européen de Marseille
    Oct 9, 2023

    Patients With Hepatitis B/C

    Not yet recruiting
    • Hepatitis B
    • Hepatitis C
    • Anti-virus treatment
    • (no location specified)
    Oct 20, 2021

    Hepatitis C Virus Infection

    Active, not recruiting
    • Hepatitis C
    • Hepatitis B
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 30, 2022

      Hepatitis B, Hepatitis C, AIDS Trial in Rouen (Blood collection using Dried Blood Spot)

      Not yet recruiting
      • Hepatitis B
      • +2 more
      • Blood collection using Dried Blood Spot
      • Rouen, France
        CSAPA la Boussole
      May 20, 2022

      Australian Hepatitis and Risk Survey in Prisons

      Recruiting
      • Hepatitis C
      • +2 more
      • Point-of-care hepatitis C antibody test
      • +5 more
      • Hume, Australian Capital Territory, Australia
      • +23 more
      Apr 20, 2023

      Evaluation of Patients With Liver Disease

      Recruiting
      • Hepatitis D
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)

        Active, not recruiting
        • Hepatitis B, Chronic
        • Tenofovir disoproxil fumarate
        • Toronto, Ontario, Canada
          University Health Network - Toronto General Hospital
        Nov 1, 2022

        HIV, Hepatitis C and Hepatitis B Infection Among Detainees in

        Recruiting
        • HIV Infections
        • +2 more
        • Rapid diagnosis test against HIV and hepatitis C and B
        • Nîmes, France
          CHU Nîmes
        Mar 17, 2022

        Population in Improving Eearly Diagnosis Efficancy in Chinese

        Recruiting
        • Carcinoma, Hepatocellular
        • +4 more
        • Liver cancer surveillance every 3 months
        • +2 more
        • Shanghai, Shanghai, China
          Department of Infectious Diseases , Ruijin Hospital, Shanghai Ji
        May 13, 2023

        QuadQuik Invitro Diagnostic Device

        Not yet recruiting
        • HIV Infections
        • +3 more
        • QuadQuik
        • San Diego, California
          Genlantis Diagnostics
        Jan 11, 2023

        Immune Response in Patients With Hepatitis B and C Infection

        Recruiting
        • Hepatitis B
        • Hepatitis C
          • Basildon, Essex, United Kingdom
            Basildon Hospital
          Apr 5, 2022

          Hepatitis B, C and D and HIV Along Maroni River Bordering French

          Completed
          • Hepatitis B
          • +5 more
          • Questionnaire
          • +6 more
          • Cayenne, French Guiana
            General Hospital of Cayenne
          Aug 10, 2021

          Hepatitis B Trial in Worldwide (GSK3228836, Nucleos(t)ide therapy)

          Recruiting
          • Hepatitis B
          • Boston, Massachusetts
          • +3 more
          Aug 24, 2022

          Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular

          Active, not recruiting
          • Hepatitis B
          • +2 more
            • Rochester, Minnesota
              Mayo Clinic
            Mar 4, 2022

            Advanced Melanoma, Hepatitis B, Hepatitis C Trial in Taipei 105

            Completed
            • Advanced Melanoma
            • +2 more
              • Taipei 105, Taiwan
                Local Institution
              Jan 11, 2022

              COVID-19 Vaccination and Prevalence of COVID-19 in Chronic Liver

              Not yet recruiting
              • Chronic or Recovered Hepatitis B
              • +4 more
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center
                Feb 2, 2023

                Hiv, Hepatitis B, Hepatitis C Trial in Almería, Tortosa (Clinical decision support system for screening of migrants using the

                Not yet recruiting
                • Hiv
                • +9 more
                • Clinical decision support system for screening of migrants using the ISMiHealth software tool.
                • Almería, Andalusia, Spain
                • +1 more
                May 10, 2023

                Viral Hepatitis B and C at PASS Consultation of Montpellier

                Recruiting
                • Hepatitis C
                • +2 more
                  • Montpellier, Hérault, France
                    CHU Montpellier, St Eloi Hospital,
                  Dec 16, 2021

                  Hepatitis B Trial in Worldwide (JNJ-73763989, JNJ-56136379, Entecavir (ETV))

                  Active, not recruiting
                  • Hepatitis B
                  • Baltimore, Maryland
                  • +9 more
                  Jan 17, 2023

                  The HOPE Study: Characterizing Patients With Hepatitis B and C

                  Recruiting
                  • Hepatitis B, Chronic
                  • Hepatitis C
                  • Blood draws
                  • +4 more
                  • Washington, District of Columbia
                  • +3 more
                  Jan 3, 2022

                  Hepatocellular Carcinoma, Hepatitis B, Hepatitis C Trial in Duarte, Singapore (MTL-CEBPA, Sorafenib)

                  Recruiting
                  • Hepatocellular Carcinoma
                  • +2 more
                  • Duarte, California
                  • +1 more
                  Feb 20, 2022

                  Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

                  Terminated
                  • Hepatitis B, Chronic
                  • Hillsborough, New Jersey
                  • +11 more
                  Dec 28, 2022